Dallas, Texas (August 2, 2011) – StockGuru shines its Spotlight on MediSwipe Inc. (http://www.MediSwipe.com) (OTCBB:MWIP), a leading company specializing in merchant payment solutions and financial products for the medical health care industries and mobile payment industry. Yesterday the company announced that it will withdraw plans to file the S-1 for the credit facility as previously announced effective immediately. The decision has been based on recent trading activity of the Company’s common stock and new interest and terms from a private institutional investor more favorable to the company. Additionally, the Company will not renew its listing on the Frankfurt Exchange, a process started by prior management. The Company closed on August 1, 2011, at $0.0094, with a fifty-two week ranged of $0.041 – 0.0086.
“There is no doubt that the concern over the proposed S-1 registration the Company was considering filing consisting of a $10,000,000 credit facility and the potential registration of several million shares into the marketplace has caused major concern with our shareholders. We are presently investigating a strategy which could have been occurring in the marketplace whereby individuals or specific firms may have allegedly taken short positions in our stock against the knowledge or strategy of millions of shares being registered. We are hoping that the cancellation of this registration and announcement of a credit line by management until more favorable terms of financing are reached will bring to light these negative events that have occurred within our marketplace over the last few months. Further, with new listing requirements going into effect on the Frankfurt Exchange, and higher scrutiny tied to dual listings, it is our desire to concentrate on building our Company and shareholder value within U.S.first and foremost,” stated B. Michael Friedman, CEO for MediSwipe Inc.
The Company has recently entered into negotiations with a private institutional investor that has offered more favorable terms to MediSwipe, including restricted stock purchases, market and financial consulting, and a registration statement that may include several investors interested in the long term value of MediSwipe. Mr. Friedman has also agreed to set up a revolving line of credit to the Company in order to meet the short term financial needs of MediSwipe until an agreed term sheet is signed. Additionally, 800 Commerce Inc. , the company’s wholly owned merchant processing division, will continue to move toward its plan for an effective spinoff this year.
“We obviously cannot control market conditions or dictate the price of our common stock. What we can and will do, is to do our best to remove all the question marks and potential factors that could potentially disrupt our business model, continue to maximize our shareholder value, and highlight what our Company represents within the sector for the immediate future,” further stated Friedman.
About MediSwipe Inc.
MediSwipe Inc. (www.MediSwipe.com) offers a full spectrum of secure and reliable transaction processing and security solutions for the medical and healthcare industries, using traditional, Internet Point-of-Sale (POS), e-commerce and mobile (wireless) payment solutions. The Company now also offers digitized personal health records in conjunction with Industry Alliance Partners. MediSwipe offers reliable merchant payment solutions and closed loop pre-paid stored value and loyalty cards as a unique cash alternative to these regulated and e-commerce businesses specializing within the healthcare sector.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of MediSwipe Inc. to be materially different from the statements made herein.
To view this StockGuru Spotlight, please visit: http://stockguru.com/category/latest-spotlights/
To get free alerts on this and other similar stocks, please register here:
What is the StockGuru Spotlight?
Many companies covered in The StockGuru Spotlight have positive increases in both volume and share price. While this is not true in all cases, StockGuru strives to cover companies in The StockGuru Spotlight that are worth of our readers’ attention.
StockGuru looks for potential break-out candidates in The StockGuru Spotlight. Many of these companies have had recent news and appear to be getting the attention of investors. StockGuru does not typically feature companies in The StockGuru Spotlight that are compensating StockGuru for this coverage. There are times when StockGuru covers a stock in The StockGuru Spotlight that had previously compensated Stockguru. Where that is the case, a proper disclosure is included below. StockGuru and its partners, employees and writers never hold shares, short positions, warrants or any other current position in a stock featured in The StockGuru Spotlight.
To feature a company in The StockGuru Spotlight please contact the Publisher at [email protected]. If our reader is a key person for a publicly traded company, StockGuru can consider that company for either a StockGuru Spotlight or a StockGuru Profile. Please contact the StockGuru Publisher John Pentony at this email address: [email protected].
Stockguru.com (“SG”) provides its members with the latest news, press releases, and trade alerts for all the companies highlighted on the site StockGuru.com. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.Stockguru.com or mentioned herein.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. StockGuru is occasionally compensated for coverage. When this is the case, SG clearly indicates this with a disclosure of all compensation received in the past and present. Additionally SG also discloses any anticipated compensation in the future. Compensation is typically in cash. Sometimes a company pays SG in restricted shares. Pentony Enterprise and its associated companies does not take free trading shares for any reason at anytime. StockGuru is not a registered investment adviser or a broker-dealer. StockGuru makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
John Pentony, Publisher, Stockguru.com
Tel: +1 469 252 3031
e-mail: [email protected]